Literature DB >> 2316646

Glucose is required to maintain ATP/ADP ratio of isolated bovine cerebral microvessels.

C G Gaposchkin1, K Tornheim, I Sussman, N B Ruderman, A L McCall.   

Abstract

Isolated bovine cerebral microvessels (ICMV) were incubated with different metabolic fuels to determine the effect of each of them on microvessel energy state. With no fuel added to the medium, the ATP/ADP generally decreased from initial values of 1.5-3 down to 1-1.5 over 4 h; the ATP content also declined approximately 50%. In contrast, with glucose present, the ATP/ADP increased, and the ATP content was maintained. Pyruvate, beta-hydroxybutyrate, glutamate, and oleate were ineffective; oleate added together with carnitine gave some improvement but less than with glucose. Oxygen consumption by ICMV did not differ appreciably in fuel-free or glucose-containing medium. Addition of an inhibitor of fatty acid oxidation, 2-tetradecylglycidate, depressed the ATP/ADP. These results suggest that ICMV require glycolysis to maintain both their content of ATP and their ATP/ADP. They also suggest that endogenous lipid is an important fuel for isolated microvessels.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316646     DOI: 10.1152/ajpendo.1990.258.3.E543

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  3 in total

1.  Effects of dexamethasone in vivo and in vitro on hexose transport in brain microvasculature.

Authors:  S R Chipkin; A van Bueren; E Bercel; C R Garrison; A L McCall
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

2.  Intracellular ATP can regulate afferent arteriolar tone via ATP-sensitive K+ channels in the rabbit.

Authors:  J N Lorenz; J Schnermann; F C Brosius; J P Briggs; P B Furspan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

3.  Atrial natriuretic peptide regulates Ca channel in early developmental cardiomyocytes.

Authors:  Lin Miao; Min Wang; Wen-Xuan Yin; Qi Yuan; Ying-Xiao Chen; Bernd Fleischmann; Jürgen Hescheler; Guangju Ji
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.